Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/13/2025

Risks of Taking Famotidine Long Term

Safety Profile and Efficacy

  • The American Academy of Pediatrics recommends that for patients requiring long-term acid suppression therapy, periodic assessment of the need for continued therapy is recommended, as tachyphylaxis can develop within 6 weeks of initiation of treatment 1
  • H2 blockers like famotidine are less effective than proton pump inhibitors (PPIs) for symptom relief and healing rates of erosive esophagitis over extended periods, with a fairly rapid tachyphylaxis potentially limiting its effectiveness for long-term use 1

Drug Interactions and Recommendations

  • The American Heart Association recommends that famotidine does not interfere with the antiplatelet activity of clopidogrel, making it a potential alternative to proton pump inhibitors in patients on dual antiplatelet therapy 2, 3
  • The National Comprehensive Cancer Network recommends that in patients with chronic myelogenous leukemia receiving dasatinib, long-term use of H2 blockers like famotidine is not recommended as it may reduce dasatinib exposure 4, 5

Long-Term Effects of Famotidine Use on Acid Suppression

Potential Concerns with Long-Term Use

  • First-generation H1R antihistamines with anticholinergic effects can be associated with cognitive decline, particularly in elderly populations, though this is less of a concern with H2 blockers like famotidine 6